Importer of Controlled Substances Registration: Johnson Matthey, Inc., 46322 [2015-19107]
Download as PDF
<![CDATA[
46322
Federal Register / Vol. 80, No. 149 / Tuesday, August 4, 2015 / Notices
Issued: July 29, 2015.
Lisa R. Barton,
Secretary to the Commission.
Controlled substance
Poppy Straw Concentrate (9670)
Fentanyl (9801) ............................
[FR Doc. 2015–18984 Filed 8–3–15; 8:45 am]
Schedule
II
II
BILLING CODE 7020–02–P
The company plans to import
thebaine derivatives and fentanyl as
reference standards.
The company plans to import the
remaining listed controlled substances
as raw materials, to be used in the
manufacture of bulk controlled
substances, for distribution to its
customers.
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Registration: Johnson Matthey, Inc.
ACTION:
Notice of registration.
Johnson Matthey, Inc. applied
to be registered as an importer of certain
basic classes of controlled substances.
The Drug Enforcement Administration
(DEA) grants Johnson Matthey, Inc.,
registration as an importer of those
controlled substances.
SUPPLEMENTARY INFORMATION: By notice
dated April 14, 2015, and published in
the Federal Register on April 22, 2015,
80 FR 22559, Johnson Matthey, Inc.,
Pharmaceutical Materials, 2003 Nolte
Drive, West Deptford, New Jersey
08066–1742 applied to be registered as
an importer of certain basic classes of
controlled substances. No comments or
objections were submitted for this
notice. Comments and requests for
hearings on applications to import
narcotic raw material are not
appropriate. 72 FR 3417, (January 25,
2007).
The DEA has considered the factors in
21 U.S.C. 823, 952(a) and 958(a) and
determined that the registration of
Johnson Matthey, Inc. to import the
basic classes of controlled substances is
consistent with the public interest and
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971. The
DEA investigated the company’s
maintenance of effective controls
against diversion by inspecting and
testing the company’s physical security
systems, verifying the company’s
compliance with state and local laws,
and reviewing the company’s
background and history.
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
with 21 CFR 1301.34, the above-named
company is granted registration as an
importer of the basic classes controlled
substances:
tkelley on DSK3SPTVN1PROD with NOTICES
SUMMARY:
Controlled substance
Schedule
Coca Leaves (9040) .....................
Thebaine (9333) ...........................
Opium, raw (9600) .......................
Noroxymorphone (9668) ..............
VerDate Sep<11>2014
18:45 Aug 03, 2015
II
II
II
II
Jkt 235001
Dated: July 29, 2015.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2015–19107 Filed 8–3–15; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. 15–15]
Adeline Davies Essien, M.D.; Decision
and Order
On March 25, 2015, Administrative
Law Judge (ALJ) Christopher B. McNeil
issued the attached Recommended
Decision. Neither party filed exceptions
to the Recommended Decision.
Having reviewed the record in its
entirety, I adopt the ALJ’s findings of
fact, conclusions of law and
recommended order.1 Accordingly, I
will order that Respondent’s DEA
Certificate of Registration be revoked
and that any pending application to
renew or modify her registration be
denied.
Order
Pursuant to the authority vested in me
by 21 U.S.C. 823(f) and 824(a)(3), as
well as 28 CFR 0.100(b), I order that
DEA Certificate of Registration
BE6969541, issued to Adeline Davies
Essien, M.D., be, and it hereby is,
revoked. I further order that any
pending application of Adeline Davies
Essien, M.D., to renew or modify her
registration, be, and it hereby is, denied.
This Order is effective September 3,
2015.
1 I take official notice of the fact that, according
to the registration records of the Agency,
Respondent retains an active registration as of this
date. Pursuant to 21 CFR 1316.59(e), Respondent
may controvert this finding by filing a properly
supported motion, no later than 10 days from the
date of this Order.
PO 00000
Frm 00089
Fmt 4703
Sfmt 4703
Dated: July 27, 2015.
Chuck Rosenberg,
Acting Administrator.
Frank W. Mann, Esq., for the
Government.
Thomas P. O’Connell, Esq., for the
Respondent.
ORDER GRANTING THE
GOVERNMENT’S MOTION FOR
SUMMARY DISPOSITION and
FINDINGS OF FACT, CONCLUSIONS
OF LAW, AND RECOMMENDED
DECISION OF THE ADMINISTRATIVE
LAW JUDGE
Administrative Law Judge
Christopher B. McNeil. On January 21,
2015, the Deputy Assistant
Administrator of the Drug Enforcement
Administration (DEA) issued an Order
to Show Cause as to why the DEA
should not revoke DEA Certificate of
Registration Number BE6969541 issued
to Adeline Davies Essien, M.D., the
Respondent in this matter. The Order
seeks to revoke Respondent’s
registration pursuant to 21 U.S.C.
824(a)(4) and 823(f), and to deny any
pending applications for renewal or
modification of such registration, and
deny any applications for any new DEA
registrations pursuant to 21 U.S.C.
823(f). As grounds for denial, the
Government alleges that Respondent is
‘‘currently without authority to handle
controlled substances in the State of
Illinois, the state in which [Respondent
is] registered with the DEA.’’
On February 27, 2015, the DEA’s
Office of Administrative Law Judges
received Respondent’s written request
for a hearing, which is dated February
26, 2015. Respondent stated that she
objected to the Government’s allegation
regarding Respondent’s authority to
handle controlled substances.
Respondent further stated that she
‘‘does have authority to practice
medicine and handle controlled
substances.’’
On March 3, 2015, this Office issued
an Order for Briefing on Allegations
Concerning Respondent’s Lack of State
Authority, Order for Prehearing
Statements, and Order Setting the
Matter for Hearing. In the Order, I
mandated that the parties provide briefs
regarding the allegation that Respondent
lacks state authority to handle
controlled substances no later than 2:00
p.m. on March 17, 2015. In my Order,
I also provided that responses to any
briefs be submitted by no later than 2:00
p.m. on March 24, 2015. On March 17,
2015, I timely received the
Government’s Response to Order and
Motion for Summary Disposition.
According to the Government’s motion,
E:\FR\FM\04AUN1.SGM
04AUN1
]]>Agencies
[Federal Register Volume 80, Number 149 (Tuesday, August 4, 2015)]
[Notices]
[Page 46322]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-19107]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Importer of Controlled Substances Registration: Johnson Matthey,
Inc.
ACTION: Notice of registration.
-----------------------------------------------------------------------
SUMMARY: Johnson Matthey, Inc. applied to be registered as an importer
of certain basic classes of controlled substances. The Drug Enforcement
Administration (DEA) grants Johnson Matthey, Inc., registration as an
importer of those controlled substances.
SUPPLEMENTARY INFORMATION: By notice dated April 14, 2015, and
published in the Federal Register on April 22, 2015, 80 FR 22559,
Johnson Matthey, Inc., Pharmaceutical Materials, 2003 Nolte Drive, West
Deptford, New Jersey 08066-1742 applied to be registered as an importer
of certain basic classes of controlled substances. No comments or
objections were submitted for this notice. Comments and requests for
hearings on applications to import narcotic raw material are not
appropriate. 72 FR 3417, (January 25, 2007).
The DEA has considered the factors in 21 U.S.C. 823, 952(a) and
958(a) and determined that the registration of Johnson Matthey, Inc. to
import the basic classes of controlled substances is consistent with
the public interest and with United States obligations under
international treaties, conventions, or protocols in effect on May 1,
1971. The DEA investigated the company's maintenance of effective
controls against diversion by inspecting and testing the company's
physical security systems, verifying the company's compliance with
state and local laws, and reviewing the company's background and
history.
Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in
accordance with 21 CFR 1301.34, the above-named company is granted
registration as an importer of the basic classes controlled substances:
------------------------------------------------------------------------
Controlled substance Schedule
------------------------------------------------------------------------
Coca Leaves (9040)......................... II
Thebaine (9333)............................ II
Opium, raw (9600).......................... II
Noroxymorphone (9668)...................... II
Poppy Straw Concentrate (9670)............. II
Fentanyl (9801)............................ II
------------------------------------------------------------------------
The company plans to import thebaine derivatives and fentanyl as
reference standards.
The company plans to import the remaining listed controlled
substances as raw materials, to be used in the manufacture of bulk
controlled substances, for distribution to its customers.
Dated: July 29, 2015.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2015-19107 Filed 8-3-15; 8:45 am]
BILLING CODE 4410-09-P
